ArticleJournal of the Korean Society of Radiology2025
Exploring the Efficacy of Artificial Intelligence-Based Computer-Aided Detection for Breast Cancer Detection on Digital Mammograms.
Article in Journal of the Korean Society of Radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What AI-CAD Detects- and Misses-in Real-World Breast Cancer Screening.Journal of the Korean Society of Radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In this retrospective study, we aimed to assess the efficacy of artificial intelligence-based computer-aided detection (AI-CAD) for breast cancer detection on mammograms. Materials and Methods: Mammograms from 269 women with breast cancer were analyzed. Cancer visibility was determined based on reports from experienced radiologists. Two expert radiologists assessed mammographic findings and breast imaging reporting and data system (BI-RADS) categories by consensus for cases of visible cancer. AI-CAD results were reviewed to determine whether AI-CAD correctly marked the cancer site. AI-CAD detection rates were analyzed according to mammographic findings, BI-RADS categories, lesion size, histologic grade, lymph node involvement, and stage. The concordance between the findings of AI-CAD and those of experienced radiologists was also assessed. Mammographically occult cases were defined as those with negative mammographic findings by two radiologists. Results: AI-CAD detected 81.4% (219/269) of cancers, with higher detection rates occurring for larger lesion sizes, high histologic grades, lymph node involvement, and advanced stages. AI-CAD detection rates were higher for architectural distortion, mass, and calcification, but lower for asymmetry. Detection rates increased with higher BI-RADS categories and a higher number of mammography findings. Concordance between the assessment of AI-CAD and that of experienced radiologists was 88.5% (238/269). AI-CAD correctly detected 19.4% (6/31) of mammographically occult cases. Conclusion: AI-CAD detected 81.4% of cancers, with substantial concordance with the findings of experienced radiologists. It correctly identified 19.4% of mammographically occult cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.